Mizuho Securities Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)

Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price ...

Related Keywords

New York , United States , Graig Suvannavejh , Axsome Therapeutics Inc , , Mizuho Securities , Axsome Therapeutics , Research Report , Moderate Buy , Axsome Therapeutic , Herriot Tabuteau ,